Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_assertion description "[This study evaluated the preclinical activity of selumetinib (AZD6244, ARRY-142866), an inhibitor of the mitogen-activated protein kinase kinase (MAPKK or MEK1/2) in 6 nasopharyngeal cancer (NPC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_assertion evidence source_evidence_literature NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_assertion SIO_000772 22565394 NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_assertion wasDerivedFrom befree-2016 NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_assertion wasGeneratedBy ECO_0000203 NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.
- befree-2016 importedOn "2016-02-19" NP980314.RAcp5Lw5JgqGUFKqdBVQegLu9otbD3Kz8RgABofFWeVXs130_provenance.